24 October, 2017 by The TZ Newswire Staff Comments Off on BofA: "The Market Implies There Is No Way A Shock Can Happen"
BofA: "The Market Implies There Is No Way A Shock Can Happen"
For today’s moment of volatility zen, we go to BofA’s Nikolay Angeloff who drew the short straw to be the (un)lucky pundit whose comments on record complacency, low volatility, etc publicized.
Angeloff starts with pointing out what we noted over the weekend , namely that we have now recorded 334 days without a 5% or more pullback (and 335 after today’s close), the fourth longest period on record since 1928.
24 October, 2017 by The TZ Newswire Staff Comments Off on Why This Acquisition Makes Delphi Automotive a Self-Driving Beast
Why This Acquisition Makes Delphi Automotive a Self-Driving Beast
Giant auto-industry supplier Delphi Automotive (NYSE: DLPH) said that it has agreed to acquire nuTonomy, a Massachusetts-based self-driving start-up, for $450 million.
This is a significant deal, one that could help Delphi move into the forefront of providers of self-driving technology — and one that may give it new ways to bring its technology to market.
24 October, 2017 by The TZ Newswire Staff Comments Off on Ionis Pharmaceuticals Tumbles on Biogen’s Miss: Buy or Sell?
Ionis Pharmaceuticals Tumbles on Biogen’s Miss: Buy or Sell?
Ionis Pharmaceuticals (NASDAQ: IONS) lost 11% of its market value after commercialization partner Biogen (NASDAQ: BIIB) reported third-quarter sales of its drug, Spinraza, that failed to match industry watchers’ forecasts. Is Ionis Pharmaceuticals’ tumble a sign that investors should sell, or a buying opportunity?
Ionis Pharmaceuticals and Biogen are collaboration partners on Spinraza, a drug used to treat spinal muscular atrophy (SMA), a rare life-threatening disease.
24 October, 2017 by The TZ Newswire Staff Comments Off on GE’s Near-Term Prognosis Goes From Bad to Worse
GE’s Near-Term Prognosis Goes From Bad to Worse
In this segment of the Motley Fool Money podcast, host Chris Hill, Million Dollar Portfolio‘s Jason Moser and Matt Argersinger, and Total Income‘s Ron Gross consider General Electric‘s (NYSE: GE) horrid quarterly report, and the market’s relatively tolerant response to it, with newish CEO John Flannery already in the process of plotting out an episode of Extreme Makeover: Conglomerate Edition for his company.
24 October, 2017 by The TZ Newswire Staff Comments Off on These Five Cognitive Biases Hurt Investors The Most
These Five Cognitive Biases Hurt Investors The Most
There is no shortage of cognitive biases out there that can trip up our brains.
By the last count, Visual Capitalist’s Jeff Desjardins notes there are 188 types of these fallible mental shortcuts in existence, and they constantly impede our ability to make the best decisions about our careers, our relationships, and for building wealth over time.
24 October, 2017 by The TZ Newswire Staff Comments Off on The New York Post: DNC and Clinton campaign funded opposition research that became Trump-Russia ‘dossier’: Washington Post
The New York Post: DNC and Clinton campaign funded opposition research that became Trump-Russia ‘dossier’: Washington Post
A lawyer who represented the Hillary Clinton presidential campaign retained the Washington research firm Fusion GPS, which then hired a former British intelligence officer to dig up dirt on Trump, according to the Washington Post.
read more
24 October, 2017 by The TZ Newswire Staff Comments Off on Corning Shines Again on Strong Specialty Materials and Optical Fiber Sales
Corning Shines Again on Strong Specialty Materials and Optical Fiber Sales
Corning Incorporated (NYSE: GLW) announced third-quarter 2017 results on Oct. 24, detailing an impressive period led by the continued outperformance of the glass technologist’s optical and specialty materials segments. In addition, Corning remains on track to meet financial targets laid out under its $22.5 billion strategic capital-allocation framework and offered an encouraging look at the rest of 2017.
Let’s take a closer look at what Corning accomplished over the past few months.